World Assets, the token issuance arm of World Foundation, completed a $65 million over-the-counter sale of WLD over the past week, with four counterparties involved. The first settlement was dated March 20. Soon after, WLD fell to around $0.24, a record low, before recovering to $0.2725. Its 24-hour gain was only 0.28%, leaving price action weak.
239 million WLD sold at an average price of $0.27
The reported OTC transaction covered about 239 million WLD at an average price of roughly $0.27. Of the total, $25 million was subject to a six-month lock-up, while the rest could enter circulation immediately after completion. That leaves direct supply pressure on the spot market. In a post on X, World Foundation said the proceeds would fund core operations, research and development, Orb manufacturing, and ecosystem growth.
Sharp discount versus the previous fundraising round
The pricing stands far below World’s fundraising round in May 2025. At that time, the project raised $135 million from investors including a16z and Bain Capital Crypto at about $1.13 per token. Compared with that level, the latest OTC sale at $0.27 reflects a discount of about 76%. Against WLD’s $11.82 high from March 2024, the token is down roughly 97%.
Large token unlock set for July 23
Supply pressure does not stop with the foundation’s sale. According to DefiLlama data, a large community token unlock is scheduled for July 23, with tokens equal to about 52.5% of WLD’s 10 billion total supply set to be released. With the token still trading near lows and fresh foundation sales already weighing on sentiment, the market’s ability to absorb that volume remains under close watch.
Regulatory scrutiny continues across several markets
The project is also dealing with legal and regulatory pressure. The report said that in October 2025, Thailand’s Securities and Exchange Commission worked with a cybercrime investigation unit to raid World’s iris-scanning sites, alleging unlicensed operations. Since launching in 2023, World has also faced regulatory questions in Indonesia, Germany, Kenya, and Brazil. The main concerns have centered on licensing and on how biometric data is collected and processed.